Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants

MLA

Javier García-Pérez, et al. “Immunogenicity of a Third Dose with MRNA-Vaccines in the ChAdOx1-S/BNT162b2 Vaccination Regimen against SARS-CoV-2 Variants.” IScience, vol. 27, no. 9, Sept. 2024. EBSCOhost, https://doi.org/10.1016/j.isci.2024.110728.

APA

Javier García-Pérez, Alberto M. Borobia, Mayte Pérez-Olmeda, Antonio Portolés, Luis Castaño, Magdalena Campins-Artí, María Jesús Bertrán, Mercedes Bermejo, José Ramón Arribas, Andrea López, Ana Ascaso-del-Rio, Eunate Arana-Arri, Inmaculada Fuentes Camps, Anna Vilella, Almudena Cascajero, María Teresa García-Morales, María Castillo de la Osa, Carla Pérez Ingidua, David Lora, … Gema González-Pardo. (2024). Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants. IScience, 27(9). https://doi.org/10.1016/j.isci.2024.110728

Chicago

Javier García-Pérez, Alberto M. Borobia, Mayte Pérez-Olmeda, Antonio Portolés, Luis Castaño, Magdalena Campins-Artí, María Jesús Bertrán, et al. 2024. “Immunogenicity of a Third Dose with MRNA-Vaccines in the ChAdOx1-S/BNT162b2 Vaccination Regimen against SARS-CoV-2 Variants.” IScience 27 (9). doi:10.1016/j.isci.2024.110728.